Cerbios founder and former president, received an honorary doctorate from St. Petersburg’s Society of Oncologists
To his surprise, last March 5,Dr. Attilio Melera, Honorary Chairman of the Board of Cerbios-Pharma S.A.(henceforth "Cerbios") received the Doctorate Honoris Causa from the Scientific Society of Oncologists of St. Petersburg .
"I didn’t expect it!" was the exclamation of Dr. Melera on the honor received during an informal meeting with Professor Vladimir Semiglazov head of the surgery department of the NN Petrov Research Institute of Oncology in St. Petersburg as well as president of the local Society of Oncology.
Dr. Melera is one of the founders of the chemical activities of Cerbios that began in 1979 with the creation of the company SAPEC SA in Barbengo (Switzerland).
Starting with two employees on the basis of a request to produce Calcium Folinate, an important product for the support of chemotherapy, SAPEC started to produce and sell this product in 1982 with significant growth in subsequent years.
SAPEC was later merged with Cernitin SA and Bioferment SA to become the current chemical division of Cerbios-Pharma S.A..
Today Cerbios counts 105 employees: it is one of the largest producers of folic acid derivatives used in cancer treatments.
Petrov Institute of Oncology
N.N. Petrov Institute of Oncology, St. Petersburg, consists of a cancer hospital (405 beds) and research facility (8 laboratories). It provides surgical, therapeutic and radiological treatment for all major types of cancer to 8000 hospital patients per year. The Institute owns a large collection of archival tissues (more than a million tumor and normal tissue blocks obtained from 270 000 patients since the year 1926). Research activities include studies of molecular mechanisms of cancer development, chemical carcinogenesis, age-related and endocrine aspects of cancer formation, etc.
N.N. Petrov Institute of Oncology has an extensive expertise in various aspects of cancer research. Patients studies include the evaluation of efficacy of various screening programs as well as clinical trials of novel treatment approaches. For more information see the following link Petrov Insitute of Oncology
Cerbios is a privately held company located in Lugano, Switzerland, that specializes in the development and manufacture of both chemical and biological APIs for its partners world-wide.
Exclusive, third-party manufacturing services are offered by the Chemical Division for HPAIs and by the Biological Division for monoclonal antibodies, recombinant proteins and pharma probiotics.
Cerbios provides full CMC support to its world-wide partners, including the supply of cGMP clinical batches, registration/validation material and commercially manufactured APIs. Paramount to this is the ability to supply all of the technical documentation and support necessary for a successful registration. Cerbios’ commercial products are marketed worldwide but primarily in Europe, USA, Japan and India.